Effect Modification by Hydroxychloroquine on the Nephrolithiasis Preventive Effect of SGLT2 Inhibitors

被引：0
|
作者：
Hsing-Chun, Miyuki [1 ]
Liu, Hsieh Chan-Jung [2 ]
Lai, Edward Chia-Cheng [1 ]
机构：
[1] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
301
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [21] Comment on "SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect"
    Peronard, Rose
    Mayntz, Stephan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (01) : 129 - 130
  • [22] Pleiotropic effects of SGLT2 inhibitors beyond the effect on glycemic control
    Hiroaki Satoh
    Diabetology International, 2018, 9 (4) : 212 - 214
  • [23] Pleiotropic effects of SGLT2 inhibitors beyond the effect on glycemic control
    Satoh, Hiroaki
    DIABETOLOGY INTERNATIONAL, 2018, 9 (04) : 212 - 214
  • [24] NEPHROPROTECTIVE EFFECT OF SGLT2 INHIBITORS DURING FIRST YEAR OF TREATMENT
    Almeida, Catarina
    Silva, Leonor
    Costa, Tiago
    Lopes, Daniela
    Andrade, Luis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1362 - 1362
  • [25] Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect
    Yau, Kevin
    Cherney, David Z. I.
    van Raalte, Daniel H.
    Wever, Britt E.
    KIDNEY INTERNATIONAL, 2024, 105 (06) : 1168 - 1172
  • [26] Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure
    Scheen, Andre J.
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (08)
  • [27] SGLT2 Inhibitors: Effect on Myocardial Infarction and Stroke in Type 2 Diabetes
    Mukhopadhyay, Pradip
    Sanyal, Debmalya
    Chatterjee, Purushottam
    Pandit, Kaushik
    Ghosh, Sujoy
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (08): : 2134 - 2140
  • [28] Ketoacidosis with SGLT2 Inhibitors
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 94 - 94
  • [29] SGLT2 inhibitors and cardioprotection
    Chen, S.
    Wang, Q.
    Christodoulou, A.
    Mylonos, N.
    Bakker, D.
    Wakker, V.
    Hollmann, M. W.
    Weber, N. C.
    Coronel, R.
    Christoffels, V.
    Andreadou, I.
    Zuurbier, C. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
  • [30] SGLT2 inhibitors: are they safe?
    Filippas-Ntekouan, Sebastian
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    POSTGRADUATE MEDICINE, 2018, 130 (01) : 72 - 82
12345